Prognostic value of blood interleukin-6 in the prediction of functional outcome after stroke: A systematic review and meta-analysis

Journal of Neuroimmunology

Volumn 274, Issue 1-2, 2014, Pages 215-224

  Bustamante, Alejandro ^a,b   Sobrino, Tomás ^c   Giralt, Dolors ^a   García Berrocoso, Teresa ^a   Llombart, Victor ^a   Ugarriza, Iratxe ^d   Espadaler, Marc ^a   Rodríguez, Noelia ^b   Sudlow, Cathie ^e   Castellanos, Mar ^f   Smith, Craig J ^g   Rodríguez Yánez, Manuel ^c   Waje Andreassen, Ulrike ^h   Tanne, David ⁱ   Oto, Jun ^j   Barber, Mark ^k   Worthmann, Hans ^l   Wartenberg, Katja E ^m   Becker, Kyra J ⁿ   Chakraborty, Baidarbhi ^o   Oh, Seung Hun ^p   Whiteley, William N ^e   Castillo, José ^c   Montaner, Joan ^a,b   more..

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c University Hospital of Santiago de Compostela   (Spain)

^d HOSPITAL DE CRUCES   (Spain)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

^g UNIVERSITY OF MANCHESTER   (United Kingdom)

^h HAUKELAND UNIVERSITY HOSPITAL   (Norway)

ⁱ TEL AVIV UNIVERSITY   (Israel)

^j UNIVERSITY OF TOKUSHIMA   (Japan)

^k NHS LANARKSHIRE   (United Kingdom)

^l HANNOVER MEDICAL SCHOOL   (Germany)

^m MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

ⁿ UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^o Padmashree Dr DY Patil Medical College   (India)

^p CHA University   (South Korea)

more..

Author keywords

Individual participant data analysis; Interleukin 6; Meta analysis; Outcome; Post stroke infection; Stroke

Indexed keywords

INTERLEUKIN 6;

AGE DISTRIBUTION; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FUNCTIONAL STATUS; HUMAN; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; STROKE PATIENT; SYSTEMATIC REVIEW;

INDIVIDUAL PARTICIPANT DATA ANALYSIS; INTERLEUKIN-6; META-ANALYSIS; OUTCOME; POST-STROKE INFECTION; STROKE;

BIOLOGICAL MARKERS; HUMANS; INTERLEUKIN-6; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECOVERY OF FUNCTION; STROKE;

EID: 84906940671     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2014.07.015     Document Type: Article

References (54)

1. Appelros P., Nydevik I., Viitanen M Poor outcome after first-ever stroke: predictors for death, dependency, and recurrent stroke within the first year Stroke 2003, 34:122-126.
2. Basic-Kes V., Simundic A.M., Nikolac N., Topic E., Demarin V Pro-inflammatory and anti-inflammatory cytokines in acute ischemic stroke and their relation to early neurological deficit and stroke outcome Clin Biochem 2008, 41:1330-1334.
3. Blanco M., Castellanos M., Rodríguez-Yáñez M., Sobrino T., Leira R., Vivancos J., Lizasoain I., Serena J., Dávalos A., Castillo J High blood pressure and inflammation are associated with poor prognosis in lacunar infarctions Cerebrovasc Dis 2006, 22:123-129.
4. Brea D., Sobrino T., Rodríguez-Yáñez M., Ramos-Cabrer P., Agulla J., Rodríguez-González R., Campos F., Blanco M., Castillo J Toll-like receptors 7 and 8 expression is associated with poor outcome and greater inflammatory response in acute ischemic stroke Clin Immunol 2011, 139:193-198.
5. Castellanos M., Castillo J., García M.M., Leira R., Serena J., Chamorro A., Dávalos A Inflammation-mediated damage in progressing lacunar infarctions: a potential therapeutic target Stroke 2002, 33:982-987.
6. Castillo J., Moro M.A., Blanco M., Leira R., Serena J., Lizasoain I., Dávalos A The release of tumor necrosis factor-alpha is associated with ischemic tolerance in human stroke Ann Neurol 2003, 54:811-819.
7. Chakraborty B., Chowdhury D., Vishnoi G., Goswami B., Kishore J., Agarwal S Interleukin-6 gene -174G/C promoter polymorphism predicts severity and outcome in acute ischemic stroke patients from north India J Stroke Cerebrovasc Dis 2013, 22:683-689.
8. De Marchis G.M., Katan M., Weck A., Fluri F., Foerch C., Findling O., Schuetz P., Buhl D., El-Koussy M., Gensicke H., Seiler M., Morgenthaler N., Mattle H.P., Mueller B., Christ-Crain M., Arnold M Copeptin adds prognostic information after ischemic stroke: results from the CoRisk study Neurology 2013, 80:1278-1286.
9. del Zoppo G., Ginis I., Hallenbeck J.M., Iadecola C., Wang X., Feuerstein G.Z Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia Brain Pathol 2000, 10:95-112.
10. DeLong E.R., DeLong D.M., Clarke-Pearson D.L Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 1988, 44:837-845.
11. DerSimonian R., Laird N Meta-analysis in clinical trials Control Clin Trials 1986, 7:177-188.
12. Domac F.M., Somay G., Misirli H., Erenoglu N.Y Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke Neurosciences (Riyadh) 2007, 12:25-30.
13. Duval S., Tweedie R Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis Biometrics 2000, 56:455-463.
14. Fluri F., Morgenthaler N.G., Mueller B., Christ-Crain M., Katan M Copeptin, procalcitonin and routine inflammatory markers-predictors of infection after stroke PLoS One 2012, 7:e48309.
15. García-Berrocoso T., Giralt D., Bustamante A., Etgen T., Jensen J.K., Sharma J.C., Shibazaki K., Saritas A., Chen X., Whiteley W.N., Montaner J B-type natriuretic peptides and mortality after stroke: a systematic review and meta-analysis Neurology 2013, 81:1976-1985.
16. García-Berrocoso T., Penalba A., Boada C., Giralt D., Cuadrado E., Colomé N., Dayon L., Canals F., Sanchez J.C., Rosell A., Montaner J From brain to blood: new biomarkers for ischemic stroke prognosis J Proteomics 2013, 94:138-148.
17. García-Berrocoso T., Giralt D., Bustamante A., Llombart V., Rubiera M., Penalba A., Boada C., Espadaler M., Molina C., Montaner J Role of beta-defensin-2 and interleukin-4 receptor as stroke outcome biomarkers J Neurochem 2014, 129:463-472.
18. Grube M.M., Koennecke H.C., Walter G., Meisel A., Sobesky J., Nolte C.H., Wellwood I., Heuschmann P.U Influence of acute complications on outcome 3months after ischemic stroke PLoS One 2013, 24:e75719.
19. Hug A., Murle B., Dalpke A., Zorn M., Liesz A., Veltkamp R Usefulness of serum procalcitonin levels for the early diagnosis of stroke-associated respiratory tract infections Neurocrit Care 2011, 14:416-422.
20. Koennecke H.C., Belz W., Berfelde D., Endres M., Fitzek S., Hamilton F., Kreitsch P., Mackert B.M., Nabavi D.G., Nolte C.H., Pohls W., Schmehl I., Schmitz B., von Brevern M., Walter G., Heuschmann P.U Factors influencing in-hospital mortality and morbidity in patients treated on a stroke unit Neurology 2011, 77:965-972.
21. Kwan J., Horsfield G., Bryant T., Gawne-Cain M., Durward G., Byrne C.D., Englyst N.A IL-6 is a predictive biomarker for stroke associated infection and future mortality in the elderly after an ischemic stroke Exp Gerontol 2013, 48:960-965.
22. Langhorne P., Stott D.J., Robertson L., MacDonald J., Jones L., McAlpine C., Dick F., Taylor G.S., Murray G Medical complications after stroke: a multicenter study Stroke 2000, 31:1223-1229.
23. Laskowitz D.T., Grocott H., Hsia A., Copeland K.R Serum markers of cerebral ischemia J Stroke Cerebrovasc Dis 1998, 7:234-241.
24. Leone M.A., Brainin M., Boon P., Pugliatti M., Keindl M., Bassetti C.L Guidance for the preparation of neurological management guidelines by EFNS scientific task forces - revised recommendations 2012 Eur J Neurol 2013, 20:410-419.
25. Moher D., Liberati A., Tetzlaff J., Altman D.G., The PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement PLoS Med 2009, 6:e1000097.
26. Montaner J., García-Berrocoso T., Mendioroz M., Palacios M., Perea-Gainza M., Delgado P., Rosell A., Slevin M., Ribó M., Molina C.A., Alvarez-Sabín J Brain natriuretic peptide is associated with worsening and mortality in acute stroke patients but adds no prognostic value to clinical predictors of outcome Cerebrovasc Dis 2012, 34:240-245.
27. Muller B Cytokine imbalance in non-immunological disease Cytokine 2002, 18:334-339.
28. Orion D., Schwammenthal Y., Reshef T., Schwartz R., Tsabari R., Merzeliak O., Chapman J., Mekori Y.A., Tanne D Interleukin-6 and soluble intercellular adhesion molecule-1 in acute brain ischaemia Eur J Neurol 2008, 15:323-328.
29. Oto J., Suzue A., Inui D., Fukuta Y., Hosotsubo K., Torii M., Nagahiro S., Nishimura M Plasma proinflammatory and anti-inflammatory cytokine and catecholamine concentrations as predictors of neurological outcome in acute stroke patients J Anesth 2008, 22:207-212.
30. Park S.Y., Kim J., Kim O.J., Kim J.K., Song J., Shin D.A., Oh S.H Predictive value of circulating interleukin-6 and heart-type fatty acid binding protein for three months clinical outcome in acute cerebral infarction: multiple blood markers profiling study Crit Care 2013, 17:R45.
31. Pencina M.J., D'Agostino R.B., D'Agostino R.B., Vasan R.S Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 2008, 27:157-172.
32. Development Core Team R A Language and Environment for Statistical Computing 2012, Foundation for Statistical Computing, Vienna, Austria, (URL http://www.R-project.org/).
33. Rodríguez J.A., Sobrino T., Orbe J., Purroy A., Martínez-Vila E., Castillo J., Páramo J.A proMetalloproteinase-10 is associated with brain damage and clinical outcome in acute ischemic stroke J Thromb Haemost 2013, 11:1464-1473.
34. Rodríguez-González R., Sobrino T., Rodríguez-Yáñez M., Millán M., Brea D., Miranda E., Moldes O., Pérez J., Lomas D.A., Leira R., Dávalos A., Castillo J Association between neuroserpin and molecular markers of brain damage in patients with acute ischemic stroke J Transl Med 2011, 9:58.
35. Rodríguez-Yáñez M., Castellanos M., Blanco M., García M.M., Nombela F., Serena J., Leira R., Lizasoain I., Dávalos A., Castillo J New-onset hypertension and inflammatory response/poor outcome in acute ischemic stroke Neurology 2006, 67:1973-1978.
36. Rodríguez-Yáñez M., Castellanos M., Sobrino T., Brea D., Ramos-Cabrer P., Pedraza S., Castiñeiras J.A., Serena J., Dávalos A., Castillo J., Blanco M Interleukin-10 facilitates the selection of patients for systemic thrombolysis BMC Neurol 2013, 13:62.
37. Saposnik G., Hill M.D., O'Donnell M., Fang J., Hachinski V., Kapral M.K., Registry of the Canadian Stroke Network for the Stroke Outcome Research Canada (SORCan) Working Group, 2008. Variables associated with 7-day, 30-day, and 1-year fatality after ischemic stroke. Stroke 39, 2318-2324.
38. Smith C.J., Emsley H., Gavin C.M., Georgiou R.F., Vail A., Barberan E.M., del Zoppo G.J., Hallenbeck J.M., Rothwell N.J., Hopkins S.J., Tyrrell P.J Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome BMC Neurol 2004, 4:2.
39. Sotgiu S., Zanda B., Marchetti B., Fois M.L., Arru G., Pes G.M., Salaris F.S., Arru A., Pirisi A., Rosati G Inflammatory biomarkers in blood of patients with acute brain ischemia Eur J Neurol 2006, 13:505-513.
40. Stewart L.A., Parmar M.K.B Meta-analysis of the literature or of individual patient data: is there a difference? Lancet 1993, 341:418-422.
41. Tzoulaki I., Siontis K.C., Evangelou E., Ioannidis J.P Bias in associations of emerging biomarkers with cardiovascular disease JAMA Int Med 2013, 173:664-671.
42. Van Wagoner N.J., Benveniste E.N Interleukin-6 expression and regulation in astrocytes J Neuroimmunol 1999, 100:124-139.
43. Vila N., Reverter J.C., Yagüe J., Chamorro A Interaction between interleukin-6 and the natural anticoagulant system in acute stroke J Interferon Cytokine Res 2000, 20:325-329.
44. Wahlgren N., Ahmed N., Eriksson N., Aichner F., Bluhmki E., Dávalos A., Erilä T., Ford G.A., Grond M., Hacke W., Hennerici M.G., Kaste M., Köhrmann M., Larrue V., Lees K.R., Machnig T., Roine R.O., Toni D., Vanhooren G Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST) Stroke 2008, 39:3316-3322.
45. Waje-Andreassen U., Krakenes J., Ulvestad E., Thomassen L., Myhr K.M., Aarseth J., Vedeler C.A IL-6: an early marker for outcome in acute ischemic stroke Acta Neurol Scand 2005, 111:360-365.
46. Wartenberg K.E., Stoll A., Funk A., Meyer A., Schmidt J.M., Berrouschot J Infection after acute ischemic stroke: risk factors, biomarkers, and outcome Stroke Res Treat 2011, 2011:830614.
47. Welsh P., Barber M., Langhorne P., Rumley A., Lowe G.D., Stott D.J Associations of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke Cerebrovasc Dis 2009, 27:247-253.
48. Whiteley W., Chong W.L., Sengupta A., Sandercock P Blood markers for the prognosis of ischemic stroke: a systematic review Stroke 2009, 40:380-389.
49. Whiteley W., Jackson C., Lewis S., Lowe G., Rumley A., Sandercock P., Wardlaw J., Dennis M., Sudlow C Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6 PLoS Med 2009, 6:e1000145.
50. Whiteley W., Wardlaw J., Dennis M., Lowe G., Rumley A., Sattar N., Welsh P., Green A., Andrews M., Sandercock P The use of blood biomarkers to predict poor outcome after acute transient ischemic attack or ischemic stroke Stroke 2012, 43:86-91.
51. Worthmann H., Tryc A.B., Goldbecker A., Ma Y.T., Tountopoulou A., Hahn A., Dengler R., Lichtinghagen R., Weissenborn K The temporal profile of inflammatory markers and mediators in blood after acute ischemic stroke differs depending on stroke outcome Cerebrovasc Dis 2010, 30:85-92.
52. Zeng L., Liu J., Wang Y., Wang L., Weng S., Chen S., Yang G.Y Cocktail blood biomarkers: prediction of clinical outcomes in patients with acute ischemic stroke Eur Neurol 2013, 69:68-75.
53. Zhang X., Wang F., Zhang Y., Ge Z Risk factors for developing pneumonia in patients with diabetes mellitus following acute ischaemic stroke J Int Med Res 2012, 40:1860-1865.
54. Zierath D., Tanzi P., Cain K., Shibata D., Becker K Plasma α-melanocyte stimulating hormone predicts outcome in ischemic stroke Stroke 2011, 42:3415-3420.